Cresco Labs (CRLBF) Total Liabilities (2019 - 2026)
Cresco Labs' (CRLBF) quarterly Total Liabilities came in at $954.6 million in Q1 2026, down 3.43% YoY from $988.5 million in Q1 2025, and up 1.04% on a QoQ basis from $944.8 million in Q4 2025.
Cresco Labs (CRLBF) Total Liabilities (2019 - 2026) Analysis & Trends
Cresco Labs (CRLBF) has 7 years of Total Liabilities data on file, last reported at $954.6 million in Q1 2026.
- Quarterly Total Liabilities fell 3.43% year-over-year to $954.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $954.6 million (down 3.43% YoY) and the FY2025 annual result came in at $944.8 million, down 2.31% from the prior year.
- Total Liabilities advanced to $954.6 million in Q1 2026, from $944.8 million in the prior quarter.
- In the past five years, Total Liabilities ranged from a high of $1.0 billion in Q1 2022 to a low of $917.4 million in Q2 2022.
- A 5-year average of $970.2 million and a median of $973.3 million in 2023 frame the typical range for Total Liabilities.
- Annual changes were most pronounced in 2022 — Total Liabilities surged 46.56% — and 2025, when it fell 7.61%.
- Tracing CRLBF's Total Liabilities over 5 years: stood at $996.0 million in 2022, then slipped by 6.59% to $930.4 million in 2023, then grew by 3.95% to $967.2 million in 2024, then fell by 2.31% to $944.8 million in 2025, then increased by 1.04% to $954.6 million in 2026.
- The last three Total Liabilities figures came in at $954.6 million (Q1 2026), $944.8 million (Q4 2025), and $940.2 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | -21.66 Bn |
| 2 | Teva Pharmaceutical Industries | 42.95 Bn | 39.30 Bn | 2.15 Bn | 32.10 Bn |
| 3 | Zoetis | 31.58 Bn | 29.90 Bn | 1.05 Bn | 11.93 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 50.85 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | 819.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 20.78 Bn |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn | 1.67 Bn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 6.97 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | 2.12 Bn |
| 10 | Cresco Labs | 295.09 Mn | 230.98 Mn | 86.95 Mn | 999.97 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 954.65 Mn |
| Dec 31, 2025 | 944.80 Mn |
| Sep 30, 2025 | 940.17 Mn |
| Jun 30, 2025 | 986.85 Mn |
| Mar 31, 2025 | 988.53 Mn |
| Dec 31, 2024 | 967.18 Mn |
| Sep 30, 2024 | 1.02 Bn |
| Jun 30, 2024 | 983.54 Mn |
| Mar 31, 2024 | 940.09 Mn |
| Dec 31, 2023 | 930.40 Mn |
| Sep 30, 2023 | 973.29 Mn |
| Jun 30, 2023 | 964.25 Mn |
| Mar 31, 2023 | 983.18 Mn |
| Dec 31, 2022 | 996.01 Mn |
| Sep 30, 2022 | 984.84 Mn |
| Jun 30, 2022 | 917.42 Mn |
| Mar 31, 2022 | 1.02 Bn |
| Dec 31, 2021 | 982.73 Mn |
| Sep 30, 2021 | 857.66 Mn |
| Mar 31, 2021 | 696.75 Mn |